These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 30396115

  • 1. Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking study.
    Najafi Z, Mahdavi M, Saeedi M, Karimpour-Razkenari E, Edraki N, Sharifzadeh M, Khanavi M, Akbarzadeh T.
    Bioorg Chem; 2019 Mar; 83():303-316. PubMed ID: 30396115
    [Abstract] [Full Text] [Related]

  • 2. Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors.
    Najafi Z, Mahdavi M, Saeedi M, Karimpour-Razkenari E, Asatouri R, Vafadarnejad F, Moghadam FH, Khanavi M, Sharifzadeh M, Akbarzadeh T.
    Eur J Med Chem; 2017 Jan 05; 125():1200-1212. PubMed ID: 27863370
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and anti-Alzheimer's activity of novel 1,2,3-triazole-chromenone carboxamide derivatives.
    Rastegari A, Nadri H, Mahdavi M, Moradi A, Mirfazli SS, Edraki N, Moghadam FH, Larijani B, Akbarzadeh T, Saeedi M.
    Bioorg Chem; 2019 Mar 05; 83():391-401. PubMed ID: 30412794
    [Abstract] [Full Text] [Related]

  • 4. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
    Cheng ZQ, Zhu KK, Zhang J, Song JL, Muehlmann LA, Jiang CS, Liu CL, Zhang H.
    Bioorg Chem; 2019 Mar 05; 83():277-288. PubMed ID: 30391700
    [Abstract] [Full Text] [Related]

  • 5. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
    Sadafi Kohnehshahri M, Chehardoli G, Bahiraei M, Akbarzadeh T, Ranjbar A, Rastegari A, Najafi Z.
    Mol Divers; 2022 Feb 05; 26(1):489-503. PubMed ID: 34491490
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer's disease.
    Rastegari A, Safavi M, Vafadarnejad F, Najafi Z, Hariri R, Bukhari SNA, Iraji A, Edraki N, Firuzi O, Saeedi M, Mahdavi M, Akbarzadeh T.
    Mol Divers; 2022 Feb 05; 26(1):409-428. PubMed ID: 34273065
    [Abstract] [Full Text] [Related]

  • 7. Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.
    Guo Y, Yang H, Huang Z, Tian S, Li Q, Du C, Chen T, Liu Y, Sun H, Liu Z.
    Molecules; 2020 Jan 23; 25(3):. PubMed ID: 31979317
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors.
    Mo J, Yang H, Chen T, Li Q, Lin H, Feng F, Liu W, Qu W, Guo Q, Chi H, Chen Y, Sun H.
    Bioorg Chem; 2019 Dec 23; 93():103310. PubMed ID: 31586704
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease.
    Hamulakova S, Janovec L, Hrabinova M, Kristian P, Kuca K, Banasova M, Imrich J.
    Eur J Med Chem; 2012 Sep 23; 55():23-31. PubMed ID: 22818849
    [Abstract] [Full Text] [Related]

  • 10. Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives as Anti-Acetylcholinesterase Agents.
    Babaee S, Chehardoli G, Akbarzadeh T, Zolfigol MA, Mahdavi M, Rastegari A, Homayouni Moghadam F, Najafi Z.
    Chem Biodivers; 2021 Jun 23; 18(6):e2000924. PubMed ID: 33861892
    [Abstract] [Full Text] [Related]

  • 11. Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease.
    Chen Y, Sun J, Peng S, Liao H, Zhang Y, Lehmann J.
    Arch Pharm (Weinheim); 2013 Dec 23; 346(12):865-71. PubMed ID: 24203864
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
    Hamulakova S, Janovec L, Hrabinova M, Spilovska K, Korabecny J, Kristian P, Kuca K, Imrich J.
    J Med Chem; 2014 Aug 28; 57(16):7073-84. PubMed ID: 25089370
    [Abstract] [Full Text] [Related]

  • 13. Alignment-independent 3D-QSAR and molecular docking studies of tacrine-4-oxo-4H-Chromene hybrids as anti-Alzheimer's agents.
    Manouchehrizadeh E, Mostoufi A, Tahanpesar E, Fereidoonnezhad M.
    Comput Biol Chem; 2019 Jun 28; 80():463-471. PubMed ID: 31170562
    [Abstract] [Full Text] [Related]

  • 14. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S, Prajapati SK, Majumdar S, Raza MK, Gabr MT, Kumar S, Pal K, Rashid H, Kumar S, Krishnamurthy S, Hoda N.
    Eur J Med Chem; 2021 Apr 05; 215():113224. PubMed ID: 33582578
    [Abstract] [Full Text] [Related]

  • 15. New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer's Disease.
    Czarnecka K, Girek M, Wójtowicz P, Kręcisz P, Skibiński R, Jończyk J, Łątka K, Bajda M, Walczak A, Galita G, Kabziński J, Majsterek I, Szymczyk P, Szymański P.
    Int J Mol Sci; 2020 May 26; 21(11):. PubMed ID: 32466601
    [Abstract] [Full Text] [Related]

  • 16. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
    Chufarova N, Czarnecka K, Skibiński R, Cuchra M, Majsterek I, Szymański P.
    Arch Pharm (Weinheim); 2018 Jul 26; 351(7):e1800050. PubMed ID: 29870588
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Thiratmatrakul S, Yenjai C, Waiwut P, Vajragupta O, Reubroycharoen P, Tohda M, Boonyarat C.
    Eur J Med Chem; 2014 Mar 21; 75():21-30. PubMed ID: 24508831
    [Abstract] [Full Text] [Related]

  • 18. Discovery of 7-O-1, 2, 3-triazole hesperetin derivatives as multi-target-directed ligands against Alzheimer's disease.
    Wang M, Fang L, Liu T, Chen X, Zheng Y, Zhang Y, Chen S, Li Z.
    Chem Biol Interact; 2021 Jun 01; 342():109489. PubMed ID: 33905740
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
    Keri RS, Quintanova C, Marques SM, Esteves AR, Cardoso SM, Santos MA.
    Bioorg Med Chem; 2013 Aug 01; 21(15):4559-69. PubMed ID: 23768661
    [Abstract] [Full Text] [Related]

  • 20. Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease.
    Chalupova K, Korabecny J, Bartolini M, Monti B, Lamba D, Caliandro R, Pesaresi A, Brazzolotto X, Gastellier AJ, Nachon F, Pejchal J, Jarosova M, Hepnarova V, Jun D, Hrabinova M, Dolezal R, Zdarova Karasova J, Mzik M, Kristofikova Z, Misik J, Muckova L, Jost P, Soukup O, Benkova M, Setnicka V, Habartova L, Chvojkova M, Kleteckova L, Vales K, Mezeiova E, Uliassi E, Valis M, Nepovimova E, Bolognesi ML, Kuca K.
    Eur J Med Chem; 2019 Apr 15; 168():491-514. PubMed ID: 30851693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.